14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $20.00 $20.00 Wednesday, 15th Apr 2020 ARQL stock ended at $20.00. During the day the stock fluctuated 0% from a day low at $20.00 to a day high of $20.00.
90 days $20.00 $20.00
52 weeks $5.76 $20.45

Historical ArQule prices

Date Open High Low Close Volume
Feb 03, 2020 $20.00 $20.00 $20.00 $20.00 0
Jan 31, 2020 $20.00 $20.00 $20.00 $20.00 0
Jan 30, 2020 $20.00 $20.00 $20.00 $20.00 0
Jan 29, 2020 $20.00 $20.00 $20.00 $20.00 0
Jan 28, 2020 $20.00 $20.00 $20.00 $20.00 0
Jan 27, 2020 $20.00 $20.00 $20.00 $20.00 0
Jan 24, 2020 $20.00 $20.00 $20.00 $20.00 0
Jan 23, 2020 $20.00 $20.00 $20.00 $20.00 0
Jan 22, 2020 $20.00 $20.00 $20.00 $20.00 0
Jan 21, 2020 $20.00 $20.00 $20.00 $20.00 0
Jan 17, 2020 $20.00 $20.00 $20.00 $20.00 0
Jan 16, 2020 $20.00 $20.00 $20.00 $20.00 0
Jan 15, 2020 $20.00 $20.00 $19.98 $20.00 6 172 607
Jan 14, 2020 $20.00 $20.01 $19.97 $19.97 2 643 477
Jan 13, 2020 $19.99 $20.01 $19.99 $19.99 1 785 268
Jan 10, 2020 $20.01 $20.02 $19.98 $19.99 3 832 407
Jan 09, 2020 $20.00 $20.02 $20.00 $20.00 2 841 118
Jan 08, 2020 $20.00 $20.02 $19.99 $20.02 5 490 751
Jan 07, 2020 $20.00 $20.04 $19.98 $20.02 6 619 035
Jan 06, 2020 $19.99 $20.05 $19.97 $20.04 13 080 017
Jan 03, 2020 $19.96 $20.00 $19.94 $19.97 3 203 395
Jan 02, 2020 $19.96 $20.00 $19.93 $19.98 4 618 370
Dec 31, 2019 $20.00 $20.00 $19.93 $19.96 2 526 324
Dec 30, 2019 $20.04 $20.08 $19.97 $19.99 2 205 222
Dec 27, 2019 $20.11 $20.14 $20.04 $20.05 2 142 318
Click to get the best stock tips daily for free!

About ArQule

ArQule ArQule, Inc., a biopharmaceutical company, researches and develops therapeutics for the treatment of cancer and rare diseases in the United States. Its lead product candidate is tivantinib (ARQ 197), a small molecule inhibitor of the c-Met receptor tyrosine kinase and its biological pathway, which is in Phase III clinical trial for the treatment of liver cancer and non-small cell lung cancer; Phase II clinical trial for the treatment of mesotheli... ARQL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT